TONI BRENT: Open Payments
NPI 1821379561 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,963 in 25 payments from 7 companies in 2025. Trend: 2023 $309 · 2024 $1,021 · 2025 $6,963
Consulting: $3,188Speaker / faculty: $1,275Food & beverage: $1,275Travel & lodging: $1,225
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $6,410 |
| Alkermes, Inc. | 3 | $255 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: CAPLYTA, LYBALVI, Auvelity, COBENFY, ARISTADA, INGREZZA, AUSTEDO XR, REXULTI.
Industry payments across AK — which companies pay providers there.
